Report from the
First Editorial Board Meeting
- Does PCSK9 have effects beyond the liver? Prof Cariou
- PCSK9 LOF mutations: mechanistic insights Prof Tybjaerg-Hansen
- Optimising PCSK9-targeted therapies - view from Europe Prof Masana
- Optimising PCSK9-targeted therapies - view from N America Prof Ginsberg